Royal Bank of Canada
IMNM icon

Royal Bank of Canada’s Immunome IMNM Stock Holding History

Royal Bank of Canada’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
4,775
+3,065
+179% +$65.6K ﹤0.01% 5399
2026
Q1 		$37K Sell
1,710
-2,390
-58% -$53.2K ﹤0.01% 5633
2025
Q4 		$88K Sell
4,100
-57,053
-93% -$1M ﹤0.01% 5264
2025
Q3 		$716K Buy
61,153
+59,640
+3,942% +$593K ﹤0.01% 4227
2025
Q2 		$14K Buy
1,513
+127
+9% +$1.04K ﹤0.01% 6378
2025
Q1 		$10K Sell
1,386
-328
-19% -$3.15K ﹤0.01% 6154
2024
Q4 		$18K Sell
1,714
-31,822
-95% -$385K ﹤0.01% 6141
2024
Q3 		$490K Buy
33,536
+782
+2% +$11.1K ﹤0.01% 4118
2024
Q2 		$397K Buy
32,754
+4,835
+17% +$75.6K ﹤0.01% 4188
2024
Q1 		$689K Sell
27,919
-1,565
-5% -$31.8K ﹤0.01% 3752
2023
Q4 		$315K Buy
29,484
+928
+3% +$7.71K ﹤0.01% 4683
2023
Q3 		$239K Sell
28,556
-241
-0.8% -$1.77K ﹤0.01% 4633
2023
Q2 		$228K Buy
28,797
+858
+3% +$4.69K ﹤0.01% 4620
2023
Q1 		$139K Buy
27,939
+62
+0.2% +$303 ﹤0.01% 4902
2022
Q4 		$61K Sell
27,877
-618
-2% -$2.49K ﹤0.01% 5766
2022
Q3 		$126K Buy
28,495
+116
+0.4% +$544 ﹤0.01% 5152
2022
Q2 		$91K Sell
28,379
-154
-0.5% -$560 ﹤0.01% 5397
2022
Q1 		$162K Buy
28,533
+330
+1% +$2.47K ﹤0.01% 5271
2021
Q4 		$366K Hold
28,203
– – ﹤0.01% 4753
2021
Q3 		$686K Buy
28,203
+76
+0.3% +$1.33K ﹤0.01% 4071
2021
Q2 		$487K Buy
28,127
+27,791
+8,271% +$614K ﹤0.01% 4310
2021
Q1 		$11K Buy
336
+147
+78% +$3.65K ﹤0.01% 6764
2020
Q4 		$2K Buy
+189
New +$2.2K ﹤0.01% 6859

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Royal Bank of Canada's IMNM Position: Q2 2026 in Review

Royal Bank of Canada increased its Immunome (IMNM) stake by 179% in Q2 2026, buying an estimated $65.6K and bringing the position to 4,775 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #5399.

Royal Bank of Canada first reported a position in IMNM in Q4 2020 and has held it in 23 quarters since. The position peaked at $716K in Q3 2025. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Royal Bank of Canada held 4,775 shares of Immunome worth $101K as of Q2 2026.
  • Royal Bank of Canada bought 3,065 Immunome shares in Q2 2026, an estimated $65.6K.
  • Immunome made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5399 holding.
  • Royal Bank of Canada first reported a position in Immunome in Q4 2020 and has held it in 23 quarters since.
  • Royal Bank of Canada's Immunome position peaked at $716K in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.